JPRN-UMIN000048782已完成未知
The therapeutic effect of Oral Semaglutide in older patients with type 2 diabetes mellitus; retrospective study. - Effect of oral Semaglutide in older patients
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 65years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with a history of hypersensitivity to the components of semaglutide 2) Patients with severe ketosis, diabetic coma or pre-coma 3) Other patients deemed to be unsuitable by the investigator
研究者
相似试验
Unknown
3 期
This trial is to see Efficacy and long-term safety of oral semaglutide versus sitagliptin in subjects with type 2 diabetesCTRI/2018/02/011670ovo Nordisk AS
进行中（未招募）
1 期
Efficacy and long-term safety of oral semaglutide versus sitagliptin in subjects with type 2 diabetesMedDRA version: 20.1 Level: LLT Classification code 10045242 Term: Type II diabetes mellitus System Organ Class: 100000004861Diabetes Mellitus, Type 2EUCTR2015-001351-71-GBovo Nordisk A/S1,863
进行中（未招募）
1 期
Efficacy and long-term safety of oral semaglutide versus sitagliptin in subjects with type 2 diabetesMedDRA version: 20.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861Diabetes Mellitus, Type 2EUCTR2015-001351-71-DEovo Nordisk A/S1,863
进行中（未招募）
1 期
Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation versus Sitagliptin in Subjects with Type 2 Diabetes MellitusMedDRA version: 20.1 Level: LLT Classification code 10045242 Term: Type II diabetes mellitus System Organ Class: 100000004861Diabetes Mellitus, Type 2EUCTR2015-005593-38-ATovo Nordisk A/S500
进行中（未招募）
1 期
Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation versus Sitagliptin in Subjects with Type 2 Diabetes MellitusDiabetes Mellitus, Type 2EUCTR2015-005593-38-BEovo Nordisk A/S500